Association of p53 immunoreactivity with high Gleason tumor grade in prostatic adenocarcinoma

Human Pathology

Volumn 25, Issue 1, 1994, Pages 92-97

  Kallakury, Bhaskar V S ^a   Figge, James ^a   Ross, Jeffrey S ^a   Fisher, Hugh A G ^a   Figge, Hellen L ^a   Jennings, Timothy A ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

benign prostatic hyperplasia; prostate cancer; tumor suppressor genes

Indexed keywords

MONOCLONAL ANTIBODY;

ANTIGEN EXPRESSION; ARTICLE; CANCER GRADING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PROSTATE ADENOCARCINOMA; PROSTATE HYPERTROPHY; PROSTATECTOMY; RETROSPECTIVE STUDY; SCORING SYSTEM; TRANSURETHRAL RESECTION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN P53; STAINING AND LABELING; SUPPORT, NON-U.S. GOV'T;

EID: 0027979718     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/0046-8177(94)90177-5     Document Type: Article

References (30)

1. Localization of gene for human p53 tumor antigen to band 17 p13
2. p53 mutations in human cancers
3. Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes
4. Wild type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles
5. p53 Cellular tumor antigen: Analysis of mRNA levels in normal adult tissues, embryos and tumors
6. Increased expression of mutant forms of p53 oncogene in primary lung cancer
7. Mutant p53 proteins bind hsp 72/73 cellular heat shock-related proteins in SV40-transformed monkey cells
8. Comparative analysis of p53 protein immunoreactivity in prostatic lung and breast carcinomas
9. Markers of the metastatic phenotype in prostate cancer
10. p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate
11. Small sub-group of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation
12. Histologic typing of prostate tumors
13. Histologic grading and clinical staging of carcinoma of the prostate
14. Veterans Administration Cooperative Urological Research Group 1974. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging
15. An immunochemical analysis of the human nuclear phosphoprotein p53: New monoclonal antibodies and epitope mapping using recombinant p53
16. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections
17. Image analysis quantitation of immunoreactive retinoblastoma protein in human thyroid neoplasms with a streptavidin-biotin-peroxidase staining technique
18. Overexpression of the p53 tumor suppressor gene product in primary lung adenocarcinomas is associated with cigarette smoking
19. Basal cell proliferation in benign prostatic hyperplasia
20. Cancer statistics 1990
21. p53 Mutations in colorectal cancer
22. Genetic basis for p53 overexpression in human breast cancer
23. Allelic loss of chromosomes 16q and 10q in human prostate cancer
24. p53 Expression in breast cancer
25. Alterations of the p53 gene are associated with the progression of a human prostate carcinoma
26. p53 Expression in colorectal adenomas
27. Mutation of the p53 gene in human acute myelogenous leukemia
28. p53 Expression in colorectal tumors
29. An approach to definition of genetic alterations in prostate cancer
30. p53 Is mutated in a subset of advanced-stage prostate cancers